The global hairy cell leukemia market is expected to register a steady revenue CAGR over the forecast period. High prevalence rate, increasing advancement, and novel innovations in the treatment market of hairy cell leukemia are key factors driving market revenue growth. Out of all types of leukemia, hairy cell leukemia is an extremely uncommon form of malignancy that only makes up around 2% of...